CRO aggressively entering into Korean markets.

Published: 2001-12-10 07:00:00

Updated: 2001-12-10 07:00:00

Many (CRO) agencies arranging foreign clinical research works for domestic companies actively came into the market as its necessity is ever demanding now in Korea, viewing that the new drug R&D was highly assessed with it good potentiality and the KFDA required high standards of clinical studies ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK